nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—PTGS2—muscle cancer	0.378	1	CbGaD
Naproxen—AKR1C3—Doxorubicin—muscle cancer	0.18	0.38	CbGbCtD
Naproxen—UGT1A1—Etoposide—muscle cancer	0.0713	0.15	CbGbCtD
Naproxen—PTGS2—Etoposide—muscle cancer	0.0429	0.0904	CbGbCtD
Naproxen—PTGS1—Etoposide—muscle cancer	0.0362	0.0763	CbGbCtD
Naproxen—SLCO1A2—Methotrexate—muscle cancer	0.0346	0.0729	CbGbCtD
Naproxen—CYP1A2—Dacarbazine—muscle cancer	0.033	0.0697	CbGbCtD
Naproxen—SLC22A6—Methotrexate—muscle cancer	0.021	0.0442	CbGbCtD
Naproxen—CYP2C8—Etoposide—muscle cancer	0.0209	0.0441	CbGbCtD
Naproxen—ALB—Methotrexate—muscle cancer	0.0179	0.0377	CbGbCtD
Naproxen—CYP1A2—Etoposide—muscle cancer	0.0162	0.0341	CbGbCtD
Naproxen—AKR1C3—Podofilox—Etoposide—muscle cancer	0.00239	0.592	CbGdCrCtD
Naproxen—AKR1C3—Vinblastine—Vincristine—muscle cancer	0.00165	0.408	CbGdCrCtD
Naproxen—Nabumetone—PTGS2—muscle cancer	0.00095	0.23	CrCbGaD
Naproxen—Carprofen—PTGS2—muscle cancer	0.000906	0.219	CrCbGaD
Naproxen—PTGS2—hindlimb—muscle cancer	0.000808	0.0875	CbGeAlD
Naproxen—PTGS2—appendage—muscle cancer	0.000693	0.0751	CbGeAlD
Naproxen—Suprofen—PTGS2—muscle cancer	0.00056	0.135	CrCbGaD
Naproxen—UGT2B7—renal system—muscle cancer	0.000558	0.0605	CbGeAlD
Naproxen—AKR1C3—smooth muscle tissue—muscle cancer	0.000535	0.058	CbGeAlD
Naproxen—Fenoprofen—PTGS2—muscle cancer	0.000482	0.117	CrCbGaD
Naproxen—UGT1A1—renal system—muscle cancer	0.000475	0.0515	CbGeAlD
Naproxen—AKR1C3—cardiac atrium—muscle cancer	0.000461	0.05	CbGeAlD
Naproxen—AKR1C3—tendon—muscle cancer	0.000402	0.0436	CbGeAlD
Naproxen—AKR1C3—bone marrow—muscle cancer	0.000389	0.0422	CbGeAlD
Naproxen—AKR1C3—vagina—muscle cancer	0.000373	0.0404	CbGeAlD
Naproxen—UGT2B7—testis—muscle cancer	0.000361	0.0391	CbGeAlD
Naproxen—Indomethacin—PTGS2—muscle cancer	0.000356	0.0861	CrCbGaD
Naproxen—AKR1C3—testis—muscle cancer	0.000333	0.0361	CbGeAlD
Naproxen—SLCO1A2—renal system—muscle cancer	0.000322	0.0349	CbGeAlD
Naproxen—Flurbiprofen—PTGS2—muscle cancer	0.000315	0.0761	CrCbGaD
Naproxen—Ketoprofen—PTGS2—muscle cancer	0.000285	0.0689	CrCbGaD
Naproxen—Ibuprofen—PTGS2—muscle cancer	0.00028	0.0678	CrCbGaD
Naproxen—PTGS2—embryo—muscle cancer	0.00023	0.0249	CbGeAlD
Naproxen—CYP2C8—renal system—muscle cancer	0.000225	0.0244	CbGeAlD
Naproxen—SLCO1A2—head—muscle cancer	0.000215	0.0233	CbGeAlD
Naproxen—CYP1A2—renal system—muscle cancer	0.00021	0.0228	CbGeAlD
Naproxen—SLCO1A2—testis—muscle cancer	0.000208	0.0225	CbGeAlD
Naproxen—ALB—testis—muscle cancer	0.000207	0.0224	CbGeAlD
Naproxen—PTGS1—smooth muscle tissue—muscle cancer	0.000189	0.0205	CbGeAlD
Naproxen—PTGS1—renal system—muscle cancer	0.000182	0.0197	CbGeAlD
Naproxen—PTGS2—smooth muscle tissue—muscle cancer	0.000181	0.0196	CbGeAlD
Naproxen—PTGS2—renal system—muscle cancer	0.000174	0.0189	CbGeAlD
Naproxen—PTGS1—cardiac atrium—muscle cancer	0.000163	0.0177	CbGeAlD
Naproxen—CYP2C8—vagina—muscle cancer	0.000163	0.0176	CbGeAlD
Naproxen—CYP2C8—testis—muscle cancer	0.000145	0.0157	CbGeAlD
Naproxen—Mood swings—Doxorubicin—muscle cancer	0.000145	0.00111	CcSEcCtD
Naproxen—Infection—Etoposide—muscle cancer	0.000144	0.0011	CcSEcCtD
Naproxen—Asthenia—Dactinomycin—muscle cancer	0.000144	0.0011	CcSEcCtD
Naproxen—Blood creatinine increased—Doxorubicin—muscle cancer	0.000143	0.00109	CcSEcCtD
Naproxen—Dysuria—Methotrexate—muscle cancer	0.000143	0.00109	CcSEcCtD
Naproxen—PTGS1—tendon—muscle cancer	0.000142	0.0154	CbGeAlD
Naproxen—Dehydration—Doxorubicin—muscle cancer	0.000142	0.00109	CcSEcCtD
Naproxen—Thrombocytopenia—Etoposide—muscle cancer	0.000142	0.00108	CcSEcCtD
Naproxen—Tachycardia—Etoposide—muscle cancer	0.000141	0.00108	CcSEcCtD
Naproxen—Abdominal pain—Vincristine—muscle cancer	0.000141	0.00108	CcSEcCtD
Naproxen—Body temperature increased—Vincristine—muscle cancer	0.000141	0.00108	CcSEcCtD
Naproxen—Liver function test abnormal—Doxorubicin—muscle cancer	0.000141	0.00108	CcSEcCtD
Naproxen—Skin disorder—Etoposide—muscle cancer	0.000141	0.00108	CcSEcCtD
Naproxen—Dry skin—Doxorubicin—muscle cancer	0.00014	0.00107	CcSEcCtD
Naproxen—Hyperhidrosis—Etoposide—muscle cancer	0.00014	0.00107	CcSEcCtD
Naproxen—Abdominal pain upper—Doxorubicin—muscle cancer	0.00014	0.00107	CcSEcCtD
Naproxen—Photosensitivity reaction—Methotrexate—muscle cancer	0.000139	0.00106	CcSEcCtD
Naproxen—Hypokalaemia—Doxorubicin—muscle cancer	0.000139	0.00106	CcSEcCtD
Naproxen—Breast disorder—Doxorubicin—muscle cancer	0.000138	0.00106	CcSEcCtD
Naproxen—Anorexia—Etoposide—muscle cancer	0.000138	0.00106	CcSEcCtD
Naproxen—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000138	0.00105	CcSEcCtD
Naproxen—Diarrhoea—Dactinomycin—muscle cancer	0.000137	0.00105	CcSEcCtD
Naproxen—Pneumonia—Methotrexate—muscle cancer	0.000137	0.00105	CcSEcCtD
Naproxen—Drowsiness—Methotrexate—muscle cancer	0.000136	0.00104	CcSEcCtD
Naproxen—PTGS2—tendon—muscle cancer	0.000136	0.0147	CbGeAlD
Naproxen—Depression—Methotrexate—muscle cancer	0.000136	0.00104	CcSEcCtD
Naproxen—Hypotension—Etoposide—muscle cancer	0.000135	0.00103	CcSEcCtD
Naproxen—Gastritis—Doxorubicin—muscle cancer	0.000135	0.00103	CcSEcCtD
Naproxen—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000135	0.00103	CcSEcCtD
Naproxen—Muscular weakness—Doxorubicin—muscle cancer	0.000135	0.00103	CcSEcCtD
Naproxen—Renal failure—Methotrexate—muscle cancer	0.000134	0.00102	CcSEcCtD
Naproxen—Abdominal distension—Doxorubicin—muscle cancer	0.000133	0.00102	CcSEcCtD
Naproxen—Stomatitis—Methotrexate—muscle cancer	0.000133	0.00101	CcSEcCtD
Naproxen—Conjunctivitis—Methotrexate—muscle cancer	0.000132	0.00101	CcSEcCtD
Naproxen—Asthma—Doxorubicin—muscle cancer	0.000132	0.00101	CcSEcCtD
Naproxen—Influenza—Doxorubicin—muscle cancer	0.000132	0.00101	CcSEcCtD
Naproxen—Dysphagia—Doxorubicin—muscle cancer	0.000132	0.00101	CcSEcCtD
Naproxen—PTGS1—vagina—muscle cancer	0.000132	0.0143	CbGeAlD
Naproxen—Hypersensitivity—Vincristine—muscle cancer	0.000132	0.00101	CcSEcCtD
Naproxen—PTGS2—bone marrow—muscle cancer	0.000132	0.0143	CbGeAlD
Naproxen—Eosinophilia—Doxorubicin—muscle cancer	0.000131	0.001	CcSEcCtD
Naproxen—Sweating—Methotrexate—muscle cancer	0.00013	0.000997	CcSEcCtD
Naproxen—Paraesthesia—Etoposide—muscle cancer	0.00013	0.000994	CcSEcCtD
Naproxen—Haematuria—Methotrexate—muscle cancer	0.00013	0.000991	CcSEcCtD
Naproxen—Pancreatitis—Doxorubicin—muscle cancer	0.00013	0.00099	CcSEcCtD
Naproxen—Dyspnoea—Etoposide—muscle cancer	0.000129	0.000987	CcSEcCtD
Naproxen—Somnolence—Etoposide—muscle cancer	0.000129	0.000984	CcSEcCtD
Naproxen—Angina pectoris—Doxorubicin—muscle cancer	0.000129	0.000984	CcSEcCtD
Naproxen—Hepatobiliary disease—Methotrexate—muscle cancer	0.000129	0.000983	CcSEcCtD
Naproxen—Epistaxis—Methotrexate—muscle cancer	0.000128	0.000981	CcSEcCtD
Naproxen—Asthenia—Vincristine—muscle cancer	0.000128	0.000981	CcSEcCtD
Naproxen—Vomiting—Dactinomycin—muscle cancer	0.000127	0.000973	CcSEcCtD
Naproxen—Bronchitis—Doxorubicin—muscle cancer	0.000127	0.000971	CcSEcCtD
Naproxen—Agranulocytosis—Methotrexate—muscle cancer	0.000127	0.00097	CcSEcCtD
Naproxen—Rash—Dactinomycin—muscle cancer	0.000126	0.000964	CcSEcCtD
Naproxen—PTGS2—vagina—muscle cancer	0.000126	0.0137	CbGeAlD
Naproxen—Decreased appetite—Etoposide—muscle cancer	0.000126	0.000962	CcSEcCtD
Naproxen—Pancytopenia—Doxorubicin—muscle cancer	0.000125	0.000959	CcSEcCtD
Naproxen—Gastrointestinal disorder—Etoposide—muscle cancer	0.000125	0.000956	CcSEcCtD
Naproxen—Fatigue—Etoposide—muscle cancer	0.000125	0.000954	CcSEcCtD
Naproxen—Pain—Etoposide—muscle cancer	0.000124	0.000947	CcSEcCtD
Naproxen—Constipation—Etoposide—muscle cancer	0.000124	0.000947	CcSEcCtD
Naproxen—Dysuria—Doxorubicin—muscle cancer	0.000124	0.000944	CcSEcCtD
Naproxen—Haemoglobin—Methotrexate—muscle cancer	0.000123	0.000938	CcSEcCtD
Naproxen—Diarrhoea—Vincristine—muscle cancer	0.000122	0.000935	CcSEcCtD
Naproxen—Haemorrhage—Methotrexate—muscle cancer	0.000122	0.000933	CcSEcCtD
Naproxen—Hepatitis—Methotrexate—muscle cancer	0.000122	0.000933	CcSEcCtD
Naproxen—Pollakiuria—Doxorubicin—muscle cancer	0.000122	0.000933	CcSEcCtD
Naproxen—PTGS1—head—muscle cancer	0.000122	0.0132	CbGeAlD
Naproxen—Pharyngitis—Methotrexate—muscle cancer	0.000121	0.000926	CcSEcCtD
Naproxen—Urinary tract disorder—Methotrexate—muscle cancer	0.000121	0.000922	CcSEcCtD
Naproxen—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000121	0.000922	CcSEcCtD
Naproxen—Urethral disorder—Methotrexate—muscle cancer	0.00012	0.000915	CcSEcCtD
Naproxen—Weight decreased—Doxorubicin—muscle cancer	0.00012	0.000914	CcSEcCtD
Naproxen—Feeling abnormal—Etoposide—muscle cancer	0.000119	0.000912	CcSEcCtD
Naproxen—Hyperglycaemia—Doxorubicin—muscle cancer	0.000119	0.000911	CcSEcCtD
Naproxen—Nausea—Dactinomycin—muscle cancer	0.000119	0.000909	CcSEcCtD
Naproxen—Pneumonia—Doxorubicin—muscle cancer	0.000119	0.000906	CcSEcCtD
Naproxen—Gastrointestinal pain—Etoposide—muscle cancer	0.000118	0.000905	CcSEcCtD
Naproxen—Dizziness—Vincristine—muscle cancer	0.000118	0.000904	CcSEcCtD
Naproxen—Drowsiness—Doxorubicin—muscle cancer	0.000118	0.0009	CcSEcCtD
Naproxen—PTGS1—testis—muscle cancer	0.000118	0.0128	CbGeAlD
Naproxen—Visual impairment—Methotrexate—muscle cancer	0.000118	0.000899	CcSEcCtD
Naproxen—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000117	0.000893	CcSEcCtD
Naproxen—PTGS2—head—muscle cancer	0.000117	0.0126	CbGeAlD
Naproxen—Renal failure—Doxorubicin—muscle cancer	0.000116	0.000885	CcSEcCtD
Naproxen—Erythema multiforme—Methotrexate—muscle cancer	0.000115	0.000883	CcSEcCtD
Naproxen—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000115	0.000882	CcSEcCtD
Naproxen—Urticaria—Etoposide—muscle cancer	0.000115	0.000879	CcSEcCtD
Naproxen—Stomatitis—Doxorubicin—muscle cancer	0.000115	0.000878	CcSEcCtD
Naproxen—Jaundice—Doxorubicin—muscle cancer	0.000115	0.000878	CcSEcCtD
Naproxen—Abdominal pain—Etoposide—muscle cancer	0.000115	0.000875	CcSEcCtD
Naproxen—Body temperature increased—Etoposide—muscle cancer	0.000115	0.000875	CcSEcCtD
Naproxen—Conjunctivitis—Doxorubicin—muscle cancer	0.000115	0.000875	CcSEcCtD
Naproxen—Urinary tract infection—Doxorubicin—muscle cancer	0.000115	0.000875	CcSEcCtD
Naproxen—Eye disorder—Methotrexate—muscle cancer	0.000114	0.000872	CcSEcCtD
Naproxen—Tinnitus—Methotrexate—muscle cancer	0.000114	0.00087	CcSEcCtD
Naproxen—Vomiting—Vincristine—muscle cancer	0.000114	0.000869	CcSEcCtD
Naproxen—Cardiac disorder—Methotrexate—muscle cancer	0.000113	0.000866	CcSEcCtD
Naproxen—Sweating—Doxorubicin—muscle cancer	0.000113	0.000863	CcSEcCtD
Naproxen—Rash—Vincristine—muscle cancer	0.000113	0.000862	CcSEcCtD
Naproxen—Dermatitis—Vincristine—muscle cancer	0.000113	0.000861	CcSEcCtD
Naproxen—Haematuria—Doxorubicin—muscle cancer	0.000112	0.000858	CcSEcCtD
Naproxen—Headache—Vincristine—muscle cancer	0.000112	0.000856	CcSEcCtD
Naproxen—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000111	0.000851	CcSEcCtD
Naproxen—Epistaxis—Doxorubicin—muscle cancer	0.000111	0.000849	CcSEcCtD
Naproxen—Angiopathy—Methotrexate—muscle cancer	0.000111	0.000847	CcSEcCtD
Naproxen—Sinusitis—Doxorubicin—muscle cancer	0.000111	0.000845	CcSEcCtD
Naproxen—Immune system disorder—Methotrexate—muscle cancer	0.00011	0.000843	CcSEcCtD
Naproxen—Mediastinal disorder—Methotrexate—muscle cancer	0.00011	0.000841	CcSEcCtD
Naproxen—Agranulocytosis—Doxorubicin—muscle cancer	0.00011	0.00084	CcSEcCtD
Naproxen—Chills—Methotrexate—muscle cancer	0.00011	0.000837	CcSEcCtD
Naproxen—Alopecia—Methotrexate—muscle cancer	0.000108	0.000825	CcSEcCtD
Naproxen—Mental disorder—Methotrexate—muscle cancer	0.000107	0.000818	CcSEcCtD
Naproxen—Hypersensitivity—Etoposide—muscle cancer	0.000107	0.000816	CcSEcCtD
Naproxen—Erythema—Methotrexate—muscle cancer	0.000106	0.000813	CcSEcCtD
Naproxen—Malnutrition—Methotrexate—muscle cancer	0.000106	0.000813	CcSEcCtD
Naproxen—Haemoglobin—Doxorubicin—muscle cancer	0.000106	0.000812	CcSEcCtD
Naproxen—Nausea—Vincristine—muscle cancer	0.000106	0.000812	CcSEcCtD
Naproxen—Rhinitis—Doxorubicin—muscle cancer	0.000106	0.00081	CcSEcCtD
Naproxen—Haemorrhage—Doxorubicin—muscle cancer	0.000106	0.000808	CcSEcCtD
Naproxen—Hepatitis—Doxorubicin—muscle cancer	0.000106	0.000808	CcSEcCtD
Naproxen—Pharyngitis—Doxorubicin—muscle cancer	0.000105	0.000802	CcSEcCtD
Naproxen—Urinary tract disorder—Doxorubicin—muscle cancer	0.000104	0.000798	CcSEcCtD
Naproxen—Oedema peripheral—Doxorubicin—muscle cancer	0.000104	0.000796	CcSEcCtD
Naproxen—Asthenia—Etoposide—muscle cancer	0.000104	0.000794	CcSEcCtD
Naproxen—Connective tissue disorder—Doxorubicin—muscle cancer	0.000104	0.000794	CcSEcCtD
Naproxen—Urethral disorder—Doxorubicin—muscle cancer	0.000104	0.000792	CcSEcCtD
Naproxen—Pruritus—Etoposide—muscle cancer	0.000103	0.000783	CcSEcCtD
Naproxen—Visual impairment—Doxorubicin—muscle cancer	0.000102	0.000779	CcSEcCtD
Naproxen—Vision blurred—Methotrexate—muscle cancer	0.0001	0.000766	CcSEcCtD
Naproxen—Erythema multiforme—Doxorubicin—muscle cancer	0.0001	0.000764	CcSEcCtD
Naproxen—Diarrhoea—Etoposide—muscle cancer	9.91e-05	0.000757	CcSEcCtD
Naproxen—Eye disorder—Doxorubicin—muscle cancer	9.88e-05	0.000755	CcSEcCtD
Naproxen—Ill-defined disorder—Methotrexate—muscle cancer	9.87e-05	0.000754	CcSEcCtD
Naproxen—Tinnitus—Doxorubicin—muscle cancer	9.86e-05	0.000754	CcSEcCtD
Naproxen—Anaemia—Methotrexate—muscle cancer	9.83e-05	0.000751	CcSEcCtD
Naproxen—Cardiac disorder—Doxorubicin—muscle cancer	9.82e-05	0.00075	CcSEcCtD
Naproxen—Angiopathy—Doxorubicin—muscle cancer	9.6e-05	0.000733	CcSEcCtD
Naproxen—Malaise—Methotrexate—muscle cancer	9.59e-05	0.000733	CcSEcCtD
Naproxen—Dizziness—Etoposide—muscle cancer	9.58e-05	0.000732	CcSEcCtD
Naproxen—Immune system disorder—Doxorubicin—muscle cancer	9.55e-05	0.00073	CcSEcCtD
Naproxen—Vertigo—Methotrexate—muscle cancer	9.55e-05	0.00073	CcSEcCtD
Naproxen—Mediastinal disorder—Doxorubicin—muscle cancer	9.53e-05	0.000728	CcSEcCtD
Naproxen—Leukopenia—Methotrexate—muscle cancer	9.52e-05	0.000727	CcSEcCtD
Naproxen—Chills—Doxorubicin—muscle cancer	9.49e-05	0.000725	CcSEcCtD
Naproxen—Arrhythmia—Doxorubicin—muscle cancer	9.45e-05	0.000722	CcSEcCtD
Naproxen—Alopecia—Doxorubicin—muscle cancer	9.35e-05	0.000714	CcSEcCtD
Naproxen—Cough—Methotrexate—muscle cancer	9.28e-05	0.000709	CcSEcCtD
Naproxen—Mental disorder—Doxorubicin—muscle cancer	9.27e-05	0.000708	CcSEcCtD
Naproxen—Convulsion—Methotrexate—muscle cancer	9.21e-05	0.000704	CcSEcCtD
Naproxen—Vomiting—Etoposide—muscle cancer	9.21e-05	0.000704	CcSEcCtD
Naproxen—Malnutrition—Doxorubicin—muscle cancer	9.21e-05	0.000704	CcSEcCtD
Naproxen—Erythema—Doxorubicin—muscle cancer	9.21e-05	0.000704	CcSEcCtD
Naproxen—Rash—Etoposide—muscle cancer	9.14e-05	0.000698	CcSEcCtD
Naproxen—Dermatitis—Etoposide—muscle cancer	9.13e-05	0.000697	CcSEcCtD
Naproxen—Headache—Etoposide—muscle cancer	9.08e-05	0.000694	CcSEcCtD
Naproxen—Flatulence—Doxorubicin—muscle cancer	9.07e-05	0.000693	CcSEcCtD
Naproxen—Myalgia—Methotrexate—muscle cancer	9.05e-05	0.000692	CcSEcCtD
Naproxen—Arthralgia—Methotrexate—muscle cancer	9.05e-05	0.000692	CcSEcCtD
Naproxen—Chest pain—Methotrexate—muscle cancer	9.05e-05	0.000692	CcSEcCtD
Naproxen—Tension—Doxorubicin—muscle cancer	9.04e-05	0.00069	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	8.99e-05	0.000687	CcSEcCtD
Naproxen—Discomfort—Methotrexate—muscle cancer	8.94e-05	0.000683	CcSEcCtD
Naproxen—Nervousness—Doxorubicin—muscle cancer	8.94e-05	0.000683	CcSEcCtD
Naproxen—Muscle spasms—Doxorubicin—muscle cancer	8.85e-05	0.000676	CcSEcCtD
Naproxen—Confusional state—Methotrexate—muscle cancer	8.75e-05	0.000669	CcSEcCtD
Naproxen—Anaphylactic shock—Methotrexate—muscle cancer	8.68e-05	0.000663	CcSEcCtD
Naproxen—Vision blurred—Doxorubicin—muscle cancer	8.68e-05	0.000663	CcSEcCtD
Naproxen—Infection—Methotrexate—muscle cancer	8.62e-05	0.000659	CcSEcCtD
Naproxen—Nausea—Etoposide—muscle cancer	8.61e-05	0.000658	CcSEcCtD
Naproxen—Ill-defined disorder—Doxorubicin—muscle cancer	8.54e-05	0.000653	CcSEcCtD
Naproxen—Nervous system disorder—Methotrexate—muscle cancer	8.51e-05	0.00065	CcSEcCtD
Naproxen—Anaemia—Doxorubicin—muscle cancer	8.51e-05	0.00065	CcSEcCtD
Naproxen—Thrombocytopenia—Methotrexate—muscle cancer	8.5e-05	0.000649	CcSEcCtD
Naproxen—Skin disorder—Methotrexate—muscle cancer	8.43e-05	0.000644	CcSEcCtD
Naproxen—Hyperhidrosis—Methotrexate—muscle cancer	8.39e-05	0.000641	CcSEcCtD
Naproxen—Malaise—Doxorubicin—muscle cancer	8.3e-05	0.000634	CcSEcCtD
Naproxen—Vertigo—Doxorubicin—muscle cancer	8.27e-05	0.000632	CcSEcCtD
Naproxen—Anorexia—Methotrexate—muscle cancer	8.27e-05	0.000632	CcSEcCtD
Naproxen—Syncope—Doxorubicin—muscle cancer	8.26e-05	0.000631	CcSEcCtD
Naproxen—Leukopenia—Doxorubicin—muscle cancer	8.24e-05	0.00063	CcSEcCtD
Naproxen—Palpitations—Doxorubicin—muscle cancer	8.14e-05	0.000622	CcSEcCtD
Naproxen—Hypotension—Methotrexate—muscle cancer	8.11e-05	0.00062	CcSEcCtD
Naproxen—Loss of consciousness—Doxorubicin—muscle cancer	8.09e-05	0.000618	CcSEcCtD
Naproxen—Cough—Doxorubicin—muscle cancer	8.03e-05	0.000614	CcSEcCtD
Naproxen—Convulsion—Doxorubicin—muscle cancer	7.98e-05	0.00061	CcSEcCtD
Naproxen—Hypertension—Doxorubicin—muscle cancer	7.95e-05	0.000607	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Methotrexate—muscle cancer	7.91e-05	0.000604	CcSEcCtD
Naproxen—Insomnia—Methotrexate—muscle cancer	7.85e-05	0.0006	CcSEcCtD
Naproxen—Arthralgia—Doxorubicin—muscle cancer	7.84e-05	0.000599	CcSEcCtD
Naproxen—Myalgia—Doxorubicin—muscle cancer	7.84e-05	0.000599	CcSEcCtD
Naproxen—Chest pain—Doxorubicin—muscle cancer	7.84e-05	0.000599	CcSEcCtD
Naproxen—Anxiety—Doxorubicin—muscle cancer	7.81e-05	0.000597	CcSEcCtD
Naproxen—Paraesthesia—Methotrexate—muscle cancer	7.79e-05	0.000595	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	7.79e-05	0.000595	CcSEcCtD
Naproxen—Discomfort—Doxorubicin—muscle cancer	7.75e-05	0.000592	CcSEcCtD
Naproxen—Dyspnoea—Methotrexate—muscle cancer	7.74e-05	0.000591	CcSEcCtD
Naproxen—Somnolence—Methotrexate—muscle cancer	7.72e-05	0.00059	CcSEcCtD
Naproxen—Dry mouth—Doxorubicin—muscle cancer	7.67e-05	0.000586	CcSEcCtD
Naproxen—Dyspepsia—Methotrexate—muscle cancer	7.64e-05	0.000584	CcSEcCtD
Naproxen—Confusional state—Doxorubicin—muscle cancer	7.58e-05	0.000579	CcSEcCtD
Naproxen—Decreased appetite—Methotrexate—muscle cancer	7.54e-05	0.000576	CcSEcCtD
Naproxen—Oedema—Doxorubicin—muscle cancer	7.51e-05	0.000574	CcSEcCtD
Naproxen—Anaphylactic shock—Doxorubicin—muscle cancer	7.51e-05	0.000574	CcSEcCtD
Naproxen—Gastrointestinal disorder—Methotrexate—muscle cancer	7.49e-05	0.000572	CcSEcCtD
Naproxen—Fatigue—Methotrexate—muscle cancer	7.48e-05	0.000572	CcSEcCtD
Naproxen—Infection—Doxorubicin—muscle cancer	7.47e-05	0.00057	CcSEcCtD
Naproxen—Pain—Methotrexate—muscle cancer	7.42e-05	0.000567	CcSEcCtD
Naproxen—Shock—Doxorubicin—muscle cancer	7.39e-05	0.000565	CcSEcCtD
Naproxen—Nervous system disorder—Doxorubicin—muscle cancer	7.37e-05	0.000563	CcSEcCtD
Naproxen—Thrombocytopenia—Doxorubicin—muscle cancer	7.36e-05	0.000562	CcSEcCtD
Naproxen—Tachycardia—Doxorubicin—muscle cancer	7.33e-05	0.00056	CcSEcCtD
Naproxen—Skin disorder—Doxorubicin—muscle cancer	7.3e-05	0.000558	CcSEcCtD
Naproxen—Hyperhidrosis—Doxorubicin—muscle cancer	7.26e-05	0.000555	CcSEcCtD
Naproxen—Anorexia—Doxorubicin—muscle cancer	7.16e-05	0.000547	CcSEcCtD
Naproxen—Feeling abnormal—Methotrexate—muscle cancer	7.15e-05	0.000546	CcSEcCtD
Naproxen—Gastrointestinal pain—Methotrexate—muscle cancer	7.1e-05	0.000542	CcSEcCtD
Naproxen—Hypotension—Doxorubicin—muscle cancer	7.02e-05	0.000537	CcSEcCtD
Naproxen—Urticaria—Methotrexate—muscle cancer	6.89e-05	0.000527	CcSEcCtD
Naproxen—Body temperature increased—Methotrexate—muscle cancer	6.86e-05	0.000524	CcSEcCtD
Naproxen—Abdominal pain—Methotrexate—muscle cancer	6.86e-05	0.000524	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Doxorubicin—muscle cancer	6.85e-05	0.000523	CcSEcCtD
Naproxen—Insomnia—Doxorubicin—muscle cancer	6.8e-05	0.000519	CcSEcCtD
Naproxen—Paraesthesia—Doxorubicin—muscle cancer	6.75e-05	0.000516	CcSEcCtD
Naproxen—Dyspnoea—Doxorubicin—muscle cancer	6.7e-05	0.000512	CcSEcCtD
Naproxen—Somnolence—Doxorubicin—muscle cancer	6.68e-05	0.00051	CcSEcCtD
Naproxen—Dyspepsia—Doxorubicin—muscle cancer	6.62e-05	0.000505	CcSEcCtD
Naproxen—Decreased appetite—Doxorubicin—muscle cancer	6.53e-05	0.000499	CcSEcCtD
Naproxen—Gastrointestinal disorder—Doxorubicin—muscle cancer	6.49e-05	0.000496	CcSEcCtD
Naproxen—Fatigue—Doxorubicin—muscle cancer	6.48e-05	0.000495	CcSEcCtD
Naproxen—Constipation—Doxorubicin—muscle cancer	6.43e-05	0.000491	CcSEcCtD
Naproxen—Pain—Doxorubicin—muscle cancer	6.43e-05	0.000491	CcSEcCtD
Naproxen—Hypersensitivity—Methotrexate—muscle cancer	6.39e-05	0.000489	CcSEcCtD
Naproxen—Asthenia—Methotrexate—muscle cancer	6.23e-05	0.000476	CcSEcCtD
Naproxen—Feeling abnormal—Doxorubicin—muscle cancer	6.19e-05	0.000473	CcSEcCtD
Naproxen—Gastrointestinal pain—Doxorubicin—muscle cancer	6.15e-05	0.00047	CcSEcCtD
Naproxen—Pruritus—Methotrexate—muscle cancer	6.14e-05	0.000469	CcSEcCtD
Naproxen—Urticaria—Doxorubicin—muscle cancer	5.97e-05	0.000456	CcSEcCtD
Naproxen—Abdominal pain—Doxorubicin—muscle cancer	5.94e-05	0.000454	CcSEcCtD
Naproxen—Body temperature increased—Doxorubicin—muscle cancer	5.94e-05	0.000454	CcSEcCtD
Naproxen—Diarrhoea—Methotrexate—muscle cancer	5.94e-05	0.000454	CcSEcCtD
Naproxen—Dizziness—Methotrexate—muscle cancer	5.74e-05	0.000439	CcSEcCtD
Naproxen—Hypersensitivity—Doxorubicin—muscle cancer	5.54e-05	0.000423	CcSEcCtD
Naproxen—Vomiting—Methotrexate—muscle cancer	5.52e-05	0.000422	CcSEcCtD
Naproxen—Rash—Methotrexate—muscle cancer	5.47e-05	0.000418	CcSEcCtD
Naproxen—Dermatitis—Methotrexate—muscle cancer	5.47e-05	0.000418	CcSEcCtD
Naproxen—Headache—Methotrexate—muscle cancer	5.44e-05	0.000415	CcSEcCtD
Naproxen—Asthenia—Doxorubicin—muscle cancer	5.39e-05	0.000412	CcSEcCtD
Naproxen—Pruritus—Doxorubicin—muscle cancer	5.32e-05	0.000406	CcSEcCtD
Naproxen—Nausea—Methotrexate—muscle cancer	5.15e-05	0.000394	CcSEcCtD
Naproxen—Diarrhoea—Doxorubicin—muscle cancer	5.14e-05	0.000393	CcSEcCtD
Naproxen—Dizziness—Doxorubicin—muscle cancer	4.97e-05	0.00038	CcSEcCtD
Naproxen—Vomiting—Doxorubicin—muscle cancer	4.78e-05	0.000365	CcSEcCtD
Naproxen—Rash—Doxorubicin—muscle cancer	4.74e-05	0.000362	CcSEcCtD
Naproxen—Dermatitis—Doxorubicin—muscle cancer	4.73e-05	0.000362	CcSEcCtD
Naproxen—Headache—Doxorubicin—muscle cancer	4.71e-05	0.00036	CcSEcCtD
Naproxen—Nausea—Doxorubicin—muscle cancer	4.46e-05	0.000341	CcSEcCtD
